Sign in
Not yet recruitingNo phase

Chlorhexidine Caps for CLABSI Prevention in Hemodialysis: a Pilot Randomized Controlled Trial

Key facts

Who runs it
The University of Queensland
Where
Australia1 site in 1 countryChoose a country to see its sites
Trial code
Status
Not yet recruiting
People taking part
60 people, planned
Started
Jun 2026
Expected to end
Feb 2028
Type of study
Interventional, 2 groupsOne group gets an existing treatment, for comparison.
Treatments tested
  • ClearGuard HD
  • B Braun Combi-stopper
Record updated
29 April 2026

Who can take part

Age
18 years and older
Sex
Women and men
Healthy volunteers
Cannot take part

The registry criteria, word for word

Show all 9 criteriaShow less

Who can take part

  • Age≥18
  • Able to provide informed consent
  • Kidney failure requiring a tunnelled CVC for treatment (haemodialysis)
  • 21 days BSI free
  • No known allergy to chlorhexidine and/or nylon and/or polypropylene

Who cannot take part

  • Known allergic to chlorhexidine and/or nylon and/or polypropylene
  • People with a cognitive impairment and/or intellectual disability
  • Current CLABSI
  • Patients on an end-of-life pathway

Where is this trial?

It has sites in one country. Choose a country to see its sites.

About the trial

What the trial wants to find out

The goal of this clinical trial is to compare a chlorhexidine antimicrobial barrier cap in patients requiring hemodialysis treatment to the standard hemodialysis caps currently used within the Metro North Kidney Health Service.

Read full original descriptionShow less

The main questions to answer are:

* Study Feasibility * Occurrence of infectious complications related to renal central venous catheters

Participants will be randomly allocated to receive either of the below hemodialysis caps to cover their hemodialysis catheter hub:

* The standard hemodialysis cap used at the Royal Brisbane and Women's Hospital, or * The intervention hemodialysis cap containing chlorhexidine inside it

Researchers will compare standard and chlorhexidine hemodialysis caps to see if the presence of chlorhexidine improves the occurrance of infectious complications related to the hemodialysis catheter.

The 2 groups in the trial

  • ControlExisting treatment, for comparison

    Standard Non-Antimicrobial Hemodialysis Cap

    Treatment: B Braun Combi-stopper

  • InterventionTreatment being tested

    Antimicrobial Haemodialysis Catheter Luer End Cap

    Treatment: ClearGuard HD

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record → Contacts and Locations

Print a page for my doctor

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
Evaluation of Chlorhexidine Caps for Central Line Associated Blood Stream Infection Prevention in People Needing Hemodialysis: a Pilot Randomised Control Trial
Record updated
29 April 2026